[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Human Growth Hormone Market By Application (Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy) By Country, Industry Analysis and Forecast, 2019 - 2025

February 2020 | 94 pages | ID: A801B8EFE6A3EN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Asia Pacific Human Growth Hormone Market would witness market growth of 9.7% CAGR during the forecast period (2019-2025).

The growth hormone helps in increasing height during childhood, raises calcium retention levels, strengthens and improves bone mineralization. It also increases the muscle mass through sarcomere hypertrophy, increases protein synthesis, promotes lipolysis, enhances the growth of all internal organs excluding the brain. The hormone has a key role to play in homeostasis, it helps to reduce glucose uptake by the liver.

Excessive release of growth hormones induces pituitary tumor, consisting of the anterior pituitary somatotroph cells. Such somatotroph cells are healthy and grow slowly, releasing excess growth hormones. This causes headaches, blurred vision due to pressure on the optic nerves, other hormonal deficiencies, and thickening of the bones of the jaw, toes, and fingers, which ultimately results in jaw heaviness and an increase in the size of the digits called acromegaly.

Growth hormone (GH) is a substance in the body that helps children grow and mature. It is made by a pituitary gland, which is a small gland between the lobes of the brain. Growth Hormone Deficiency (GHD) is a well-known clinical condition in adults. It is characterized by defects in the metabolism of the substrate, body composition, physical and psychosocial functioning, all of which increase after GH replacement.

Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.

Scope of the Study

Market Segmentation:

By Application
  • Small for Gestational Age
  • Prader-Willi Syndrome
  • Idiopathic Short Stature
  • Turner Syndrome
  • Growth Hormone Deficiency and
    • Pediatric Growth Hormone Deficiency
    • Adult Growth Hormone Deficiency
  • Other Applications
By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Merck Group
  • Teva Pharmaceuticals Industries Ltd.
  • Ipsen Pharma Biotech SAS
  • Novartis AG (Sandoz International GmbH)
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
  • Ferring Holdings SA
      • Novo Nordisk A/S
  • Eli Lilly and Company
  • Anhui Anke Biotechnology Group Co., Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Asia Pacific Human Growth Hormone Market, by Application
  1.4.2 Asia Pacific Growth Hormone Deficiency Market, by Type
  1.4.3 Asia Pacific Human Growth Hormone Market, by Distribution Channel
  1.4.4 Asia Pacific Human Growth Hormone Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY APPLICATION

3.1 Asia Pacific Small for Gestational Age Market by Country
3.2 Asia Pacific Prader-Willi Syndrome Market by Country
3.3 Asia Pacific Idiopathic Short Stature Market by Country
3.4 Asia Pacific Turner Syndrome Market by Country
3.5 Asia Pacific Growth Hormone Deficiency Market by Country
  3.5.1 Asia Pacific Growth Hormone Deficiency Application Market by Type
    3.5.1.1 Asia Pacific Pediatric Growth Hormone Deficiency Market by Country
    3.5.1.2 Asia Pacific Adult Growth Hormone Deficiency Market by Country
3.6 Asia Pacific Other Applications Market by Country

CHAPTER 4. ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL

4.1 Asia Pacific Retail Pharmacy Market by Country
4.2 Asia Pacific Hospital Pharmacy Market by Country
4.3 Asia Pacific Specialty Pharmacy Market by Country
4.4 Asia Pacific Online Pharmacy Market by Country

CHAPTER 5. ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY COUNTRY

5.1 China Human Growth Hormone Market
  5.1.1 China Human Growth Hormone Market by Application
    5.1.1.1 China Growth Hormone Deficiency Application Market by Type
  5.1.2 China Human Growth Hormone Market by Distribution Channel
5.2 Japan Human Growth Hormone Market
  5.2.1 Japan Human Growth Hormone Market by Application
    5.2.1.1 Japan Growth Hormone Deficiency Application Market by Type
  5.2.2 Japan Human Growth Hormone Market by Distribution Channel
5.3 India Human Growth Hormone Market
  5.3.1 India Human Growth Hormone Market by Application
    5.3.1.1 India Growth Hormone Deficiency Application Market by Type
  5.3.2 India Human Growth Hormone Market by Distribution Channel
5.4 South Korea Human Growth Hormone Market
  5.4.1 South Korea Human Growth Hormone Market by Application
    5.4.1.1 South Korea Growth Hormone Deficiency Application Market by Type
  5.4.2 South Korea Human Growth Hormone Market by Distribution Channel
5.5 Singapore Human Growth Hormone Market
  5.5.1 Singapore Human Growth Hormone Market by Application
    5.5.1.1 Singapore Growth Hormone Deficiency Application Market by Type
      5.5.1.1.1 Singapore Human Growth Hormone Market by Distribution Channel
5.6 Malaysia Human Growth Hormone Market
  5.6.1 Malaysia Human Growth Hormone Market by Application
    5.6.1.1 Malaysia Growth Hormone Deficiency Application Market by Type
  5.6.2 Malaysia Human Growth Hormone Market by Distribution Channel
5.7 Rest of Asia Pacific Human Growth Hormone Market
  5.7.1 Rest of Asia Pacific Human Growth Hormone Market by Application
    5.7.1.1 Rest of Asia Pacific Growth Hormone Deficiency Application Market by Type
  5.7.2 Rest of Asia Pacific Human Growth Hormone Market by Distribution Channel

CHAPTER 6. COMPANY PROFILES

6.1 Merck Group
  6.1.1 Company Overview
  6.1.2 Financial Analysis
  6.1.3 Segmental and Regional Analysis
  6.1.4 Research & Development Expense
  6.1.5 Recent strategies and developments:
    6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
  6.2.1 Company Overview
  6.2.2 Financial Analysis
  6.2.3 Regional Analysis
  6.2.4 Research & Development Expenses
  6.2.5 Recent strategies and developments:
    6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
  6.3.1 Company Overview
  6.3.2 Financial Analysis
  6.3.3 Segmental and Regional Analysis
  6.3.4 Research & Development Expense
  6.3.5 Recent strategies and developments:
    6.3.5.1 Partnerships, Collaborations, and Agreements:
    6.3.5.2 Product Launches and Product Expansions:
    6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
  6.4.1 Company Overview
  6.4.2 Financial Analysis
  6.4.3 Segmental and Regional Analysis
  6.4.4 Research & Development Expense
  6.4.5 Recent strategies and developments:
    6.4.5.1 Partnerships, Collaboration, and Agreements:
    6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
  6.5.1 Company Overview
  6.5.2 Financial Analysis
  6.5.3 Segmental and Regional Analysis
  6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
  6.6.1 Company Overview
  6.6.2 Financial Analysis
  6.6.3 Segmental and Regional Analysis
  6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
  6.7.1 Company Overview
  6.7.2 Financial Analysis
  6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
  6.8.1 Company Overview
  6.8.2 Financial Analysis
  6.8.3 Segmental & Regional Analysis
  6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
  6.9.1 Company Overview
  6.9.2 Financial Analysis
  6.9.3 Regional Analysis
  6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
  6.10.1 Company Overview

LIST OF TABLES

TABLE 1 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 CHINA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 CHINA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 CHINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 CHINA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 CHINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 CHINA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 CHINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 CHINA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 JAPAN HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 JAPAN HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 JAPAN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 JAPAN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 JAPAN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 JAPAN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 JAPAN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 JAPAN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 INDIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 INDIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 INDIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 INDIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 INDIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 INDIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 INDIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 INDIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 SOUTH KOREA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 SOUTH KOREA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 SOUTH KOREA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SOUTH KOREA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SOUTH KOREA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 SOUTH KOREA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 SOUTH KOREA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 SOUTH KOREA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 SINGAPORE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 68 SINGAPORE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 69 SINGAPORE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 70 SINGAPORE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 71 SINGAPORE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SINGAPORE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SINGAPORE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 74 SINGAPORE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 75 MALAYSIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 76 MALAYSIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 77 MALAYSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 MALAYSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 MALAYSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 MALAYSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 MALAYSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 MALAYSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 84 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 85 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 REST OF ASIA PACIFIC GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF ASIA PACIFIC GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 90 REST OF ASIA PACIFIC HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 91 KEY INFORMATION – MERCK GROUP
TABLE 92 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 93 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 94 KEY INFORMATION – NOVARTIS AG
TABLE 95 KEY INFORMATION – PFIZER, INC.
TABLE 96 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 97 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 98 KEY INFORMATION – NOVO NORDISK A/S
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH


More Publications